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Background
We have previously demonstrated that intramuscular
immunization with recombinant adenovirus (rAd)-based
HIV/SIV vaccine candidates elicits robust mucosal CD8+
T-lymphocyte responses (Kaufman et al., J Immunol
2009, 181: 4188–98). Elucidating the mechanisms under-
lying the priming, trafficking and differentiation of rAd-
elicited mucosal CD8+ T-lymphocytes may prove critical
for optimizing mucosal cellular immunity generated by
these vaccine vectors.
Methods
rAd-elicited CD8+ T-lymphocyte priming and trafficking
were evaluated using adoptive transfer studies in C57BL/
6 mice. The genotypic and phenotypic properties of vac-
cine-elicited CD8+ T-lymphocytes were characterized in
systemic and mucosal microenvironments using gene
expression profiling and polyfunctional intracellular
cytokine staining.
Results
Using adoptive transfer of CFSE-labeled T-lymphocytes,
we demonstrated that intramuscular rAd immunization
induced CD8+ T-lymphocyte priming in peripheral
lymph nodes draining the inoculation site but not at dis-
tant systemic or mucosal lymphoid inductive sites.
Primed CD8+ T-lymphocytes subsequently migrated to
mucosal lymphoid inductive sites, including mesenteric
lymph nodes and Peyer's patches, upregulated mucosal
homing markers and acquired the capacity to traffic to
mucosal effector surfaces. The influx of systemic vaccine-
elicited CD8+ T-lymphocytes into mucosal tissues
accounted for the vast proportion mucosal CD8+ T-lym-
phocyte responses generated by intramuscular rAd immu-
nization. Vaccine-elicited CD8+ T-lymphocytes migrating
to the intestinal mucosa rapidly acquired genotypic prop-
erties typical of gut-resident T-lymphocytes, which
included upregulation of genes involved in both immune
activation and senescence. Mucosal vaccine-elicited CD8+
T-lymphocytes also retained the capacity to elaborate
multiple effector functions, including TNF-α, IFN-γ and
IL-2 production and cytotoxic degranulation.
Conclusion
Intramuscular rAd immunization licenses vaccine-elicited
systemic CD8+ T-lymphocytes to traffic to mucosal sur-
faces and undergo microenvironment-specific patterns of
differentiation. These data have important implications
for the development of vaccines against mucosal patho-
gens.
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